| [1] | Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, et al. (2009) Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17: 763–771. doi: 10.1111/j.1524-475x.2009.00543.x
|
| [2] | Werdin F, Tennenhaus M, Schaller HE, Rennekampff HO (2009) Evidence-based Management Strategies for Treatment of Chronic Wounds. Eplasty 9: 169–179.
|
| [3] | Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366: 1719–1724. doi: 10.1016/s0140-6736(05)67698-2
|
| [4] | Edwards J, Stapley S (2010) Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 1: 1–40. doi: 10.1002/14651858.cd003556.pub2
|
| [5] | Wu Y, Chen L, Scott PG, Tredget EE (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648–2659. doi: 10.1634/stemcells.2007-0226
|
| [6] | Cohen MA, Eaglstein WH (2001) Recombinant human platelet-derived growth factor gel speeds healing of acute full-thickness punch biopsy wounds. J Am Acad Dermatol 45: 857–862. doi: 10.1067/mjd.2001.117721
|
| [7] | Fang RC, Galiano RD (2008) A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics 2: 1–12. doi: 10.2147/btt.s1338
|
| [8] | Senet P, Vicaut E, Beneton N, Debure C, Lok C, et al. (2011) Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB. A randomized controlled trial. Arch Dermatol 147: 926–930. doi: 10.1001/archdermatol.2011.84
|
| [9] | Chan RK, Liu PH, Pietramaggiori G, Ibrahim SI, Hechtman HB, et al. (2006) Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice. J Burn Care Res 27: 202–205. doi: 10.1097/01.bcr.0000202898.11277.58
|
| [10] | Niezgoda JA, Van Gils CC, Frykberg RG, Hodde JP (2005) Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care 18: 258–266. doi: 10.1097/00129334-200506000-00012
|
| [11] | Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL (2003) Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90: 133–146. doi: 10.1002/bjs.4019
|
| [12] | Chiang B, Essick E, Ehringer W, Murphree S, Hauck MA, et al. (2007) Enhancing skin wound healing by direct intracellular ATP delivery. Am J Surg 193: 213–218. doi: 10.1016/j.amjsurg.2006.08.069
|
| [13] | Wang J, Zhang Q, Wan R, Mo Y, Li M, et al. (2009) Intracellular ATP-delivery enhanced skin wound healing in rabbits. Ann Plast Surg 62: 180–186. doi: 10.1097/sap.0b013e31817fe47e
|
| [14] | Wang J, Wan R, Mo Y, Li M, Zhang Q, et al. (2010) Intracellular delivery of ATP enhanced healing process in full-thickness skin wounds in diabetic animals. Am J Surg 199: 823–832. doi: 10.1016/j.amjsurg.2009.05.040
|
| [15] | Chien S (2010) Intracellular ATP delivery using highly fusogenic liposomes. Methods Mol Biol 605: 377–392. doi: 10.1007/978-1-60327-360-2_26
|
| [16] | Chien S (2007) Ischemic rabbit ear model created by minimally invasive surgery. Wound Repair Regen 15: 928–935. doi: 10.1111/j.1524-475x.2007.00285.x
|
| [17] | Chien S, Wilhelmi BJ (2012) A simplified technique for producing an ischemic wound model. J Vis Exp 2012: 1–12. doi: 10.3791/3341
|
| [18] | Chvapil M, Gaines JA, Gilman T (1988) Lanolin and epidermal growth factor in healing of partial-thickness pig wounds. J Burn Care Rehabil 9: 279–284. doi: 10.1097/00004630-198805000-00009
|
| [19] | Chien S (2010) Metabolic management. In: Toledo-Pereyra LH, editors. Organ Procurement and preservation for transplantation. Austin, TX: Landes Bioscience. pp. 82–123. Available: http://eurekah.com/chapter/3992).
|
| [20] | Coleman R (2011) Picrosirius red staining revisited. Acta Histochem 113: 231–233. doi: 10.1016/j.acthis.2010.02.002
|
| [21] | Villiers E, Baines S, Law AM, Mallows V (2006) Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody. Vet Clin Pathol 35: 55–71. doi: 10.1111/j.1939-165x.2006.tb00089.x
|
| [22] | Schaffer M, Witte M, Becker HD (2002) Models to study ischemia in chronic wounds. Int J Low Extrem Wounds 1: 104–111. doi: 10.1177/1534734602001002005
|
| [23] | Park JE, Barbul A (2004) Understanding the role of immune regulation in wound healing. Am J Surg 187: 11S–16S. doi: 10.1016/s0002-9610(03)00296-4
|
| [24] | Kloeters o, Tandara A, Mustoe TA (2007) Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 15: S40–S45. doi: 10.1111/j.1524-475x.2007.00224.x
|
| [25] | Saulis AS, Mogford JH, Mustoe TA (2002) Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg 110: 177–183. doi: 10.1097/00006534-200207000-00029
|
| [26] | Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, et al. (2009) Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17: 763–771. doi: 10.1111/j.1524-475x.2009.00543.x
|
| [27] | Bennett JP, Matthews R, Faulk WP (1980) Treatment of chronic ulceration of the legs with human amnion. Lancet 1: 1153–1156. doi: 10.1016/s0140-6736(80)91616-5
|
| [28] | Howes EL (1943) The rate and nature of epithelization in wounds with loss of substance. SGO 76: 738–745.
|
| [29] | Game FL, Hinchliffe RJ, Apelqvist J, Armstrong DG, Bakker K, et al. (2012) A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 28 Suppl 1119–141. doi: 10.1002/dmrr.2246
|
| [30] | Steed DL (2006) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117: 143S–149S. doi: 10.1097/01.prs.0000222526.21512.4c
|
| [31] | Cheng B, Liu HW, Fu XB, Sun TZ, Sheng ZY (2007) Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats. J Dermatol Sci 45: 193–201. doi: 10.1016/j.jdermsci.2006.11.014
|
| [32] | Simons M (2005) Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? J Am Coll Cardiol 46: 835–837. doi: 10.1016/j.jacc.2005.06.008
|
| [33] | Landsman A, Agnew P, Parish L, Joseph R, Galiano RD (2010) Diabetic foot ulcers treated with becaplermin and TheraGauze, a moisture-controlling smart dressing: a randomized, multicenter, prospective analysis. J Am Podiatr Med Assoc 100: 155–160. doi: 10.7547/1000155
|
| [34] | Greener B, Hughes AA, Bannister NP, Douglass J (2005) Proteases and pH in chronic wounds. J Wound Care 14: 59–61.
|
| [35] | Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, et al. (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7: 442–452. doi: 10.1046/j.1524-475x.1999.00442.x
|
| [36] | Ovington LG, Schultz GS (2004) The physiology of wound healing. In: Morison MJ, Ovington LG, Wilkie K, Moffatt CJ, Franks PJ, editors. Chronic wound care. St. Louis: Mosby. pp. 83–100.
|
| [37] | Harding KG, Morris HL, Patel GK (2002) Science, medicine and the future: healing chronic wounds. BMJ 324: 160–163. doi: 10.1136/bmj.324.7330.160
|
| [38] | Silver IA (1980) The physiology of wound healing. In: Hunt TK, editors. Wound healing and wound infection. Theory and surgical practice. New York: Appleton. pp. 11–31.
|
| [39] | Im MJC, Hoopes JE (1970) Energy metabolism in healing skin wounds. J Surg Res 10: 459–464. doi: 10.1016/0022-4804(70)90070-3
|
| [40] | Berendt AR (2006) Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis 43: 193–198. doi: 10.1086/505223
|
| [41] | Niinikoski J (2003) Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making. Wound Repair Regen 11: 458–461. doi: 10.1046/j.1524-475x.2003.11610.x
|
| [42] | Smith DG, Mills WJ, Steen RG, Williams D (1999) Levels of high energy phosphate in the dorsal skin of the foot in normal and diabetic adults: the role of 31P magnetic resonance spectroscopy and direct quantification with high pressure liquid chromatography. Foot Ankle Int 20: 258–262. doi: 10.1177/107110079902000409
|
| [43] | Hunt TK, Pai MP (1972) The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 135: 561–567.
|
| [44] | Wang D, Huang NN, Heppel LA (1990) Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters. Biochem Biophys Res Commun 166: 251–258. doi: 10.1016/0006-291x(90)91938-o
|
| [45] | Lindblad WJ (2007) Editorial: How should one study wound healing? Wound Repair Regen 14: 515. doi: 10.1111/j.1743-6109.2006.00171.x
|
| [46] | Cooper GM (1997) The cell. A molecular approach. Washington, DC: ASM Press. 517 p.
|
| [47] | Puisieux F, Fattal E, Lahiani M, Auger J, Jouannet P, et al. (1994) Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP). in vitro and in vivo studies. J Drug Target 2: 443–448. doi: 10.3109/10611869408996820
|
| [48] | Chien S (2006) Development of direct intracellular energy delivery techniques for treatment of tissue ischemia. Recent Res Devel Biophys 5: 1–37.
|
| [49] | Chien S, Tseng M, Li M, Tobin G, Banis J (2007) Intracellular ATP delivery caused extremely fast granular tissue growth in rabbits. Wound Repair Regen 15: A39.
|
| [50] | Wang J, Li M, Chien S (2008) Intracellular delivery of ATP enhanced healing process of full-thickness skin wounds in diabetic animals. Wound Repair Regen 16: A56.
|
| [51] | Levenson SM, Demetriou AA (1992) Metabolic factors. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing. Biochemical & clinical aspects. Philadelphia: Saunders. pp. 248–273.
|
| [52] | Williams-Boyce PK, Daniel JC Jr (1986) Comparison of ear tissue regeneration in mammals. J Anat 149: 55–63.
|
| [53] | van Furth R, Cohn ZA (1968) The origin and kinetics of mononuclear phagocytes. J Exp Med 128: 415–435. doi: 10.1084/jem.128.3.415
|
| [54] | Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723–737. doi: 10.1038/nri3073
|
| [55] | Sawyer RT, Strausbauch PH, Volkman A (1982) Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest 46: 165–170.
|
| [56] | Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, et al. (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284–1288. doi: 10.1126/science.1204351
|
| [57] | Randolph GJ (2011) Immunology. No need to coax monocytes. Science 332: 1268–1269. doi: 10.1126/science.1208480
|
| [58] | Papatriantafyllou M (2011) Macrophages: support from the locals. Nat Rev Immunol 11: 442. doi: 10.1038/nri3016
|
| [59] | Tacke F, Kurts C (2011) Infiltrating monocytes versus resident Kupffer cells: do alternatively activated macrophages need to be targeted alternatively? Hepatology 54: 2267–2270. doi: 10.1002/hep.24714
|
| [60] | Wang X, Sansam CG, Thom CS, Metzger D, Evans JA, et al. (2009) Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. Cancer Res 69: 8094–8101. doi: 10.1158/0008-5472.can-09-0733
|
| [61] | Martinet W, Verheye S, De Meyer GR (2007) Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death. Trends Cardiovasc Med 17: 69–75. doi: 10.1016/j.tcm.2006.12.004
|
| [62] | Vaage J, Harlos JP (1991) Collagen production by macrophages in tumor encapsulation and dormancy. Br J Cancer 63: 758–762.
|
| [63] | Peng X, Mathai SK, Murray LA, Russell T, Reilkoff R, et al. (2011) Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor beta1-induced lung fibrosis. Fibrogenesis Tissue Repair 4: 1–12. doi: 10.1186/1755-1536-4-12
|
| [64] | Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, et al. (2009) Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68: 762–773. doi: 10.1097/nen.0b013e3181aa31c2
|
| [65] | Vaage J, Lindblad WJ (1990) Production of collagen type I by mouse peritoneal macrophages. J Leukoc Biol 48: 274–280.
|
| [66] | Laskin DL, Sunil VR, Gardner CR, Laskin JD (2011) Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51: 267–288. doi: 10.1146/annurev.pharmtox.010909.105812
|
| [67] | Van den BJ, Lamers WH, Koehler ES, Geuns JM, Alhonen L, et al. (2012) Pivotal Advance:Arginase-1-independent polyamine production stimulates the expression of IL-4-induced alternatively activated macrophage markers while inhibiting LPS-induced expression of inflammatory genes. J Leukoc Biol 91: 1–15. doi: 10.1189/jlb.0911453
|
| [68] | Classen A, Lloberas J, Celada A (2009) Macrophage activation: classical versus alternative. Methods Mol Biol 531: 29–43. doi: 10.1007/978-1-59745-396-7_3
|
| [69] | Sorensen V, Wiedlocha A, Haugsten EM, Khnykin D, Wesche J, et al. (2006) Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail. J Cell Sci 119: 4332–4341. doi: 10.1242/jcs.03209
|
| [70] | Roy S, Driggs J, Elgharably H, Biswas S, Findley M, et al. (2011) Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wound Repair Regen 19: 753–766. doi: 10.1111/j.1524-475x.2011.00740.x
|
| [71] | Zamora DO, Natesan S, Becerra S, Wrice N, Chung E, et al. (2013) Enhanced wound vascularization using a dsASCs seeded FPEG scaffold. Angiogenesis 16: 745–757. doi: 10.1007/s10456-013-9352-y
|
| [72] | Lubkowska A, Dolegowska B, Banfi G (2012) Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents 26: 3S–22S.
|
